MTIP

MTIP is a Swiss-based growth capital investor specializing in the healthcare sector. Founded by entrepreneurs, their firm partners with innovative companies in the digital health, medical technology and healthcare services segments to create cost-effective and socially responsible solutions for improving patient care. Supported by seasoned investment professionals and a proprietary network of research institutions and medical facilities, we provide financial and strategic assistance from the market entry through expansion stages. Simply put, their goal is to empower talented entrepreneurs to develop successful and sustainable businesses with clear competitive advantages.
MD

Marc Dietrich

Investment Director

Christoph Kausch

Managing Partner

CM

Christoph Mårtensson

Investment Associate

CV

Christoph Vonder Mühll

Partner, CFO

ZC

Zhao C.A.I.A., C.F.A., Danchen

Investment Director

17 past transactions

ReActive Robotics

Series B in 2017
Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for the successful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.

Cynerio Israel Ltd

Seed Round in 2019
Cynerio develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats. Its platform provides device behavior learning with medical workflow analysis to provide full visibility of what devices are doing on the network and associated risk, detecting anomalous activity, and stopping the threat. Daniel Brodie and Leon Lerman founded Cynerio in 2017.Its headquarters is in Tel Aviv in Israel.

Mediktor Corp

Venture Round in 2021
Mediktor is the most advanced and accurate expert system for pre-diagnoses, triage and decision-making support. The first artificial intelligent system clinically validated that is transforming healthcare for everyone. A technology that finally makes it possible to reduce access barriers to healthcare: - Patients can make better decisions from the first symptoms - And the healthcare system can organize its demand and optimize resources to offer a better medical coverage.

Lynxcare, Inc.

Series A in 2022
Lynxcare, Inc., an AI powered data platform, collects and analyses structured and unstructured data from various sources to provide actionable insights for medical professionals. It serves hospitals and clinics. The company was founded in 2015 and is based in San Francisco, California.

Oviva

Series C in 2021
Oviva provides technology-enabled dietetic services and their goal is to help people lead happier & healthier lives. They have developed unique, personalised behaviour change programmes that combine our smartphone app and learning portal to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.

Lumeon

Series D in 2020
Lumeon Ltd., a digital health company, provides care pathway management solutions to the healthcare industry. The company offers Care Pathway Manager, a cloud-based platform that provides a single real-time view of patient journey from referral to outcome. Its services include business analysis, project management, configuration and data migration, training, and support. Lumeon Ltd. was formerly known as Qinec Ltd. and changed its name to Lumeon Ltd. in July 2016. The company was founded in 2005 and is based in London, United Kingdom.

Cynerio Israel Ltd

Series B in 2021
Cynerio develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats. Its platform provides device behavior learning with medical workflow analysis to provide full visibility of what devices are doing on the network and associated risk, detecting anomalous activity, and stopping the threat. Daniel Brodie and Leon Lerman founded Cynerio in 2017.Its headquarters is in Tel Aviv in Israel.

Blueprint Genetics

Series A in 2017
Blueprint Genetics Oy provides clinical genetics testing followed by blueprint and customized next-generation sequencing services. The company provide services that include one-off sequencing projects, and tailored sequencing and bioinformatics platforms to address specific sequencing needs. It also offers custom services for researchers and diagnostics providers. Blueprint Genetics Oy was founded in 2012 and is based in Helsinki, Finland. As of January 21, 2020, Blueprint Genetics Oy operates as a subsidiary of Quest Diagnostics Incorporated.

Apricity

Series B in 2022
Apricity Fertility UK Limited develops an artificial technology based online platform for fertility treatments and medications. The company offers Apricity, a mobile application, which provides medical tests results and updates, fertility advisors' guidance, healthcare coordination facilities, medications list, and appointment services. The company was founded in 2018 and is headquartered in London, United Kingdom. It has an additional office in Paris, France.

Intelligencia

Series A in 2021
Intelligencia is an enterprise SaaS company that applies Machine Learning to assess and mitigate the risk in clinical development strategy/design.

Koa Health B.V.

Series A in 2021
Koa Health is digital wellbeing and therapeutics solutions combine the latest clinical research and breakthrough technologies. It delivers mental health support that is accessible, personalized, and effective across a range of conditions. They create digital tools and resources for mental health that encompass prevention, prediction, and treatment.

TrialBee

Venture Round in 2020
Trialbee AB designs and develops a software as a service (SaaS) based patient matching and engagement solution for participating in clinical trials. It enables candidates for searching a range of clinical trials and analysis, awareness, pre-screening, and report services. The company offers patient recruitment, enrollment, and retention services through resource library, adherence reminders, and patient journey. It serves sponsors, CRO's, investigator sites, and patients. The company was founded in 2010 and is based in Malmö, Sweden.

Lumeon

Series C in 2018
Lumeon Ltd., a digital health company, provides care pathway management solutions to the healthcare industry. The company offers Care Pathway Manager, a cloud-based platform that provides a single real-time view of patient journey from referral to outcome. Its services include business analysis, project management, configuration and data migration, training, and support. Lumeon Ltd. was formerly known as Qinec Ltd. and changed its name to Lumeon Ltd. in July 2016. The company was founded in 2005 and is based in London, United Kingdom.

Oviva

Series B in 2020
Oviva provides technology-enabled dietetic services and their goal is to help people lead happier & healthier lives. They have developed unique, personalised behaviour change programmes that combine our smartphone app and learning portal to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.

TytoCare Ltd.

Series C in 2018
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

NitiNotes

Series A in 2018
Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.

ReActive Robotics

Series A in 2016
Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for the successful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.